| MI (fatal or non- fatal) |
Stroke (fatal or non-fatal) |
Neuropathy | Retinopathy | Nephropathy | |
|---|---|---|---|---|---|
| Demographics | |||||
| Age, years | 0.04363 | 0.02896 | 0.03022 | 0.02285 | −0.01938 |
| Women | −0.20660 | − 0.00326 | −0.1868 | 0.2264 | −0.01129 |
| Ethnicity | |||||
| Black | −0.11630 | 0.2716 | −0.09448 | −0.1677 | 0.08812 |
| Hispanic or Latino | 0.2338 | ||||
| Clinical features | |||||
| Tobacco smoking, current | 0.2358 | 0.1665 | 0.1483 | ||
| SBP (mmHg) | −0.00514 | 0.01659 | 0.00456 | 0.00824 | 0.00303 |
| History of CVD | 0.9618 | 0.4138 | 0.26672 | 0.1127 | −0.02164 |
| Drug use | |||||
| BP lowering drugs | −0.12480 | 0.1598 | 0.18192 | 0.06393 | −0.07952 |
| Statins | 0.04699 | − 0.18870 | |||
| Anticoagulants | 0.544 | − 0.13870 | 0.03199 | ||
| Oral diabetes drugs | −0.25747 | −0.2349 | −0.1256 | ||
| Biomarkers | |||||
| HbA1c, % | 0.2135 | 0.3365 | 0.18866 | 0.1449 | 0.1369 |
| Total cholesterol, mg/dL | 0.00019 | 0.00171 | 0.00219 | −0.00017 | −0.00111 |
| HDL cholesterol, mg/dL | −0.01358 | − 0.00639 | −0.00539 | 0.00545 | 0.00629 |
| Serum creatine, mg/DL | 0.08027 | 0.5955 | 0.604442 | 0.6947 | 0.8609 |
| Urine albumin:creatine ratio, mg/g | 0.00042 | 0.0003 | 0.0002 | 0.00036 | |